Our laboratory has reported that NO via the iNOS up-regulation contributed to the development of ARDS in children with enterovirus infection, patients with leptospirosis and scrub tybus and animal with hypercalcemia and endotoxemia [31-34]. The gene discussed is NOS2; the disease is serum lipopolysaccharide activity.